Coronary artery disease is a major cause of death throughout the world. Restoration and maintenance of the blood supply to the heart muscle is of vital importance for the prevention of morbidity and mortality.

Bio Nova has conducted “proof of concept” studies that demonstrated that living endothelial cells firmly attach to the surface of collagen-based tissue scaffolds built from Bio Nova Technology. The Company plans to develop a small diameter tube suitable for the attachment and growth of the patient’s own living endothelial cells.